Dr. James D. Relle, MD

Dr. Relle practices at Michigan Institute of Urology in Saint Clair Shores, Michigan.

Dr. Relle's NPI, 1215919048, was assigned on November 17, 2005. Dr. Relle holds Michigan license 4301062234.

Dr. Relle's primary practice is Michigan Institute of Urology, at 20952 12 Mile Rd, Saint Clair Shores, MI 48081 in Macomb County. The practice phone is (586) 771-4820.

Dr. Relle's primary practice is Michigan Institute of Urology in Saint Clair Shores, Michigan. Dr. Relle is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Relle to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Relle practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Relle's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Relle is licensed in Michigan.

CMS data shows 9,523 Medicare services from Dr. Relle across 47 procedure codes in 2024, for 1,172 Medicare patients. Medicare paid $389,349 for them.

CMS counts 1,172 Medicare patients who saw Dr. Relle in 2024. The largest group is 75 to 84, with 473 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Relle's median patient age at 71, with 23% women.

In 2024, Dr. Relle wrote 3,541 Medicare Part D claims for 954 patients. 91% of them were for generic drugs. CMS names the drug for 3,402 of them, across 30 drugs with 11 or more claims each, at $341,726 in total drug cost. In 2023, CMS named 3,027 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Relle for performance year 2024, reported individually. Dr. Relle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Relle as offering telehealth. CMS counts 28 procedures of prostate resection by Dr. Relle, more than 90% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Relle, published from 2016 to 2021. 2020 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Erectile Dysfunction and High-Intensity Focused Ultrasound Ablation. Dr. Relle's most frequent co-authors are Harjivan Singh Kohli, MD, Katarzyna Jadwiga Macura, MD, PhD and Kiran Reddi Nandalur, MD.

Dmand AI links Dr. Relle to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 453 general payments to Dr. Relle from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Astellas Pharma US Inc paid the most, $934.